January 28, 2019
NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark  this link  for your convenience.


We hope you can join us for the NRG Oncology Semiannual Meeting and Birthday Celebration, February 7-9, 2019, at the Phoenix Convention Center in Phoenix, AZ. Pre-Registration is now closed. Please register onsite at the Phoenix Convention Center.

 

Help Celebrate Our Birthday at the NRG Oncology Semiannual Meeting in Phoenix, AZ
We hope you can join us for the NRG Oncology Semiannual Meeting and Birthday Celebration, February 7-9, 2019, at the Phoenix Convention Center in Phoenix, AZ. Pre-Registration is now closed. Please register onsite at the Phoenix Convention Center.

 

Our Gift to You

It’s our birthday, and we are celebrating the reason for our success – our members! We are extending our birthday gift to you. In honor of our 5th birthday, NRG Oncology is waiving the registration fee for all NRG Oncology members. Please be sure to register onsite if you did not pre-register.

Get the Meeting App – EVENTSXD

Download EVENTSXD to your electronic device to quickly access agendas, meeting room information, and more! Create an account and select the NRG Oncology Semiannual Meeting. Access the Agenda and create your own personal agenda by tapping the green star in order to “favorite” specific sessions.

 

CCD 800-line Coverage during the Meeting
Information regarding the availability of the NRG Oncology-Pittsburgh Center Clinical Coordinating Department (CCD) during the NRG Oncology meeting is posted to the NRG Oncology meeting page and the CTSU website.

 

CTN/CRA Educational Programs Thursday, February 7 and Friday, February 8

Slide sets for the PSC Introduction to Clinical Trials: Principles of Clinical Trial Management and for the PSC Clinical Trials Nurse/Clinical Research Associate Educational Session are posted to the Nurses and CRA /Education and Training tab on the NRG Oncology website. (A password is required.) If you plan to attend these sessions, please download the slides and handouts prior to the meeting and bring them with you. Also, please check the NRG Oncology website frequently prior to the meeting, as additional presentations and handouts may be added. No handouts will be provided at the meeting.

 


CLOSURES
BREAST

NSABP B-39: Study Closure Notice and Patient Letter (posted to CTSU and NRG Oncology)

 

NSABP B-40: Study Closure Notice and Patient Letter (posted to CTSU and NRG Oncology)


AMENDMENTS
GYNECOLOGIC

NRG-GY016: Amendment 1, version date: December 11, 2018 and Amendment 2 in response to Action Letter, version date: January 16, 2019 (posted to CTSU)


OTHER PROTOCOL NOTICES

1. Children’s Oncology Group Protocol AGCT1531: “A Phase III Trial of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors” is open to patient entry. It is available on the CTSU menu with Dr. Allan Covens as NRG Champion. Please enroll your eligible patients to this important trial.Enrollment credited to NRG Oncology will count towards membership requirements.

 

2. BREAST

NSABP B-55: IMPORTANT NOTICE! NRG Oncology is closely monitoring accrual to this rapidly enrolling trial. (Information posted to CTSU)

 

3. GYNECOLOGIC

NRG-GY005/GY012 Blood Pressure Cuff Update

It has been confirmed by AstraZeneca and VWR that a restock supply has been received. VWR is prioritizing shipments for pending orders and VWR is ready to receive new orders. Enrollment of new patients may now continue. Thank you for your patience.

 

NRG-GY008: All patients are now off study treatment.  For those sites who received drug, remaining inventory is to be documented on the DARF and unused drug is to be destroyed as per institutional policy and recorded on the DARF.  Please submit your final DARF to  

NRG-GY-Regulatory@nrgoncology.org 

 

NRG-GY004 Data Freeze - March 2019

NRG-GY004 is maturing for the final analysis. Please ensure all data is up to date (including follow-up information), and all queries are answered. We expect to start the final analysis in March 2019.  We will provide the results of this important study to you as soon as possible. If you have any questions please contact Sandy Dascomb at [ DascombS@NRGOncology.org].

 

Form TR for Biospecimens Shipped to NRG Biospecimen Bank-Columbus

Please note that the NRG Patient ID (e.g., AB###-GY###-#####) must be included on any copies of Form TR shipped to the NRG Biospecimen Bank-Columbus. If the NRG Patient ID does not appear on the top, left of Form TR, please hand-complete the NRG Patient ID before sending the form to the NRG Biospecimen Bank-Columbus. Do not complete the NRG Patient ID for forms accompanying biospecimens shipped to laboratories other than the NRG Biospecimen Bank-Columbus. Please contact the NRG Biospecimen Bank-Columbus at bpcbank@nationwidechildrens.org  if you need assistance or have additional questions.

 

Biospecimen Bank-Columbus & SDMC Undergoing Refurbishment

Please be advised that the data exchange between the Biospecimen Bank-Columbus and SDMC is undergoing refurbishment. During this time, biospecimen receipt information will not appear in Rave or SEDES. Biospecimen transmittal forms (i.e., Form SP and Form TR) will ultimately not appear as overdue during this time; however, there may be a brief period over the next several weeks during which forms may temporarily appear as overdue. If this should occur or if you experience any other issues, please notify Support at support@nrgoncology.org. Sites should continue to return inquiries from Biospecimen Bank-Columbus staff regarding biospecimen receipt during this time.

4. VTOC TRAINING

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, and NRG-CC004. Space is limited so register now and reserve your seat. The next training is scheduled for February 7, 2019 at the NRG Oncology Semiannual Meeting.

 

DRUG SAFETY UPDATES

 

Safety updates have been issued for the following studies:

DRUG NAME

PROTOCOL

WEBSITE FOR SAFETY REPORTS

Atezolimumab

NRG-GI004

NRG-GY009

NRG-GY017

CTSU

CTSU

NRG

Cabozantanib

NRG-GY001

CTSU

Nivolumab

NRG-BN002

NRG-GY003

NRG

NRG

Olaparib

NSABP B-55

CTSU

Trametinib

GOG-0281

CTSU

PUBLICATIONS REMINDERS

Please note the following upcoming meeting and abstract submission deadline dates

Upcoming Meetings

American Association for Cancer Research (AACR); Mar 29 - Apr 3, 2019; Atlanta, GA


American Society of Clinical Oncology (ASCO) GU
; Feb 14-16, 2019; San Francisco, CA


Society of Gynecologic Oncology (SGO)
; Mar 16-19, 2019; Honolulu, HI


Society of Surgical Oncology (SSO)
; Mar 27-30, 2019 ; San Diego, CA


St. Gallen Breast Cancer Conference (SG-BCC);
Mar 20-23, 2019; Vienna, Austria


Upcoming Abstract Submission Deadlines

American Association of Physicists in Medicine (AAPM); Jul 14-18, 2019; San Antonio, TX; due to publications committee Feb 21, 2019; meeting submission deadline Mar 7, 2019

American Society of Clinical Oncology (ASCO); May 31 - Jun 4, 2019; Chicago, IL; due to publications committee Jan 28, 2019; meeting submission deadline Feb 12, 2019; LBA Mar 14, 2019 noon ET


American Society for Radiation Oncology (ASTRO)
; Sep 15-18, 2019; Chicago, IL; due to publications committee Jan 30, 2019; meeting submission deadline Feb 24, 2019


ESMO Breast Cancer Annual Congress
; May 2-4, 2019; Berlin, Germany; meeting submission deadline Jan 30, 2019 TIP, LBA placeholder noon CET (Central European Time); LBA deadline Apr 1, 2019 noon CEST (Central European Summer Time)


International Society for Quality of Life Research (ISOQOL)
; Oct 20-23, 2019; San Diego, CA; due to publications committee Mar 26 2019; meeting submission deadline Apr 8, 2019

 

 

 

NRG Oncology is proud to be an active participant of #CancerMoonShot.
This message was sent from NRG-Broadcasts@NRGOncology.org to NRG-Broadcasts@NRGOncology.org
Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Update Profile/Email Address | Forward Email | Report Abuse